Clik here to view.
How to bring drugs to market in Singapore, the world’s most efficient...
This second blog in our series on health technology assessments (HTAs) in the Asia-Pacific (APAC) region examines the process by which HTAs are conducted in Singapore and what this means for market...
View ArticlePatient advocates speak out on partnering with life science companies
What does patient centricity mean from a patient’s point of view, and what kind of support do patient advocates need from life science companies? Three prominent patient advocates shared their...
View ArticleState review boards take on drug prices amid Congressional inaction
How are states tackling high drug prices and increasing affordability? Clarivate market access expert Stephanie Hoops discusses the emergence of affordability review boards. Done waiting for Congress...
View ArticleUnique insights to inform strategic portfolio strategy
Learn how Neuland Laboratories, an India- based API manufacturer leveraged a combination of Cortellis Generics Intelligence and Cortellis Competitive Intelligence for trusted information around target...
View ArticleAccelerating drug discovery at the Melbourne Biomedical Precinct
33% of Australia’s 2017-2018 drug discovery efforts occurred within the Melbourne Biomedical Precinct (the Precinct) and continues to grow. The Precinct consistently attracts 23% of National Health and...
View ArticleStreamline regulatory requirements monitoring and distribution
The regulatory intelligence team at a medium-sized pharmaceutical company was challenged to stay on top of on-going legislative changes across a variety of regions and disease areas, to support teams...
View Article